• Concerta 18 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	18 mg

  ATC: N06B N06BA N06BA04

• Concerta 27 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	27 mg

  ATC: N06B N06BA N06BA04

• Concerta 36 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  METHYLPHENIDATE	36 mg

  ATC: N06B N06BA N06BA04

• Concerta 54 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  METHYLPHENIDATE HYDROCHLORIDE	54 mg

  ATC: N06B N06BA N06BA04

• Durogesic Matrix 100 microgram/h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	16,8 mg

  ATC: N02A N02AB N02AB03

• Durogesic Matrix 12 micrograms/h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	2,1 mg

  ATC: N02A N02AB N02AB03

• Durogesic Matrix 25 micrograms/h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	4,2 mg

  ATC: N02A N02AB N02AB03

• Durogesic Matrix 50 micrograms/h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	8,4 mg

  ATC: N02A N02AB N02AB03

• Durogesic Matrix 75 micrograms/h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  FENTANYL	12,6 mg

  ATC: N02A N02AB N02AB03

• Eprex 1000 IU/0.5 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	8,4 µg

  ATC: B03X B03XA B03XA01

• Eprex 10000 IU/1 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	0,084 mg

  ATC: B03X B03XA B03XA01

• Eprex 2000 IU/0.5 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	16,8 mg

  ATC: B03X B03XA B03XA01

• Eprex 3000 UI/0.3 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	25,2 µg

  ATC: B03X B03XA B03XA01

• Eprex 4000 IU/0.4 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	33,6 µg

  ATC: B03X B03XA B03XA01

• Eprex 40000 IU/ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ALFA	40000 UI

  ATC: B03X B03XA B03XA01

• Pariet 10 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  RABEPRAZOLE SODIUM	10 mg

  ATC: A02B A02BC A02BC04

• Pariet 20 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  RABEPRAZOLE SODIUM	20 mg

  ATC: A02B A02BC A02BC04

• Risperdal 1 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	1 mg

  ATC: N05A N05AX N05AX08

• Risperdal 1 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  RISPERIDONE	1 mg

  ATC: N05A N05AX N05AX08

• Risperdal 3 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	3 mg

  ATC: N05A N05AX N05AX08

• Risperdal 6 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  RISPERIDONE	6 mg

  ATC: N05A N05AX N05AX08

• Risperdal Consta 25 mg powder and solvent for prolonged-release suspension for intramuscular injection

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	25 mg

  ATC: N05A N05AX N05AX08

• Risperdal Consta 50 mg powder and solvent for prolonged-release suspension for intramuscular injection

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	50 mg

  ATC: N05A N05AX N05AX08

• Risperdal Consta, 37.5 mg powder and solvent for prolonged-release suspension for intramuscular injection

  Form: powder and solvent for preparation of prolonged-release injectable suspension

  Active substance	Dosage
  RISPERIDONE	37,5 mg

  ATC: N05A N05AX N05AX08

• Sporanox 100 mg capsules

  Form: capsules, hard

  Active substance	Dosage
  ITRACONAZOLE	100 mg

  ATC: J02A J02AC J02AC02